✦ LIBER ✦

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

✍ Scribed by Ioannis Kostopoulos; Petroula Arapantoni-Dadioti; Helen Gogas; Savvas Papadopoulos; Vasiliki Malamou-Mitsi; Chrisoula D. Scopa; Sofia Markaki; Evangelia Karagianni; Vasiliki Kyriakou; Anastasia Margariti; Elisavet Kyrkou; Kitty Pavlakis; Thomas Zaramboukas; Anna Skordalaki; Antonia Bourli; Christos Markopoulos; Dimitrios Pectasides; Meletios A. Dimopoulos; Dimosthenis Skarlos; George Fountzilas

Publisher: Springer US
Year: 2006
Tongue: English
Weight: 406 KB
Volume: 96
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-005-9062-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Triple-negative phenotype is of adverse

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

✍ P. Skarlos; C. Christodoulou; K. T. Kalogeras; A. G. Eleftheraki; M. Bobos; A. B 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 992 KB

The prognostic value of Stathmin-1, S100

The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study

✍ Rastko Golouh; Tanja Cufer; Aleksander Sadikov; Petra Nussdorfer; Pernille Autze 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 335 KB

Prognostic value of the quantitative mea

Prognostic value of the quantitative measurement of the oncoprotein p185Her-2/neu in a group of patients with breast cancer and positive node involvement

✍ Uriel Bohn; José Aguiar; Cristina Bilbao; Adolfo Murias; Victor Vega; Ricardo Ch 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 109 KB

## Abstract Our study attempts to determine the prognostic value of the quantitative measurement of the oncoprotein p185^Her‐2/neu^ in a group of patients with breast cancer and positive node involvement. In a series of 217 patients with breast cancer and positive nodes in whom the oncoprotein p185

A pilot study of adjuvant nanoparticle a

A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer

✍ Denise Yardley; Howard Burris; Nancy Peacock; Eric Raefsky; Marianne Melnik; Rog 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 171 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views